BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27183031)

  • 1. SAFETY AND EFFICACY OF INTRAVITREAL DEXAMETHASONE IMPLANTS IN THE MANAGEMENT OF MACULAR EDEMA SECONDARY TO INFECTIOUS UVEITIS.
    Fonollosa A; Llorenç V; Artaraz J; Jimenez B; Ruiz-Arruza I; Agirrebengoa K; Cordero-Coma M; Costales-Mier F; Adan A
    Retina; 2016 Sep; 36(9):1778-85. PubMed ID: 27183031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
    Khurana RN; Porco TC
    Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis.
    Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A
    Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.
    Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J
    Retina; 2013; 33(7):1435-40. PubMed ID: 23514796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series.
    Larochelle MB; Smith J; Dacey MS
    Am J Ophthalmol; 2016 Jun; 166():149-153. PubMed ID: 27066725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.
    Fabiani C; Vitale A; Emmi G; Lopalco G; Vannozzi L; Bacherini D; Guerriero S; Favale RA; Fusco F; Franceschini R; Frediani B; Iannone F; Galeazzi M; Tosi GM; Cantarini L
    J Ocul Pharmacol Ther; 2017 Sep; 33(7):549-555. PubMed ID: 28557602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Intravitreal Dexamethasone Implant for Refractory Uveitic Macular Edema in Adults and Children.
    Ratra D; Barh A; Banerjee M; Ratra V; Biswas J
    Ocul Immunol Inflamm; 2018; 26(7):1034-1040. PubMed ID: 29394119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.
    Nobre-Cardoso J; Champion E; Darugar A; Fel A; Lehoang P; Bodaghi B
    Ocul Immunol Inflamm; 2017 Aug; 25(4):447-454. PubMed ID: 27003221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of dexamethasone intravitreal implant for refractory macular edema in children.
    Lei S; Lam WC
    Can J Ophthalmol; 2015 Jun; 50(3):236-41. PubMed ID: 26040225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of an intravitreal dexamethasone implant for the treatment of noninfectious uveitic macular edema.
    Habot-Wilner Z; Sorkin N; Goldenberg D; Loewenstein A; Goldstein M
    Ophthalmologica; 2014; 232(2):77-82. PubMed ID: 25012541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease.
    Fabiani C; Emmi G; Lopalco G; Vannozzi L; Bacherini D; Guerriero S; Franceschini R; Frediani B; Iannone F; Marco Tosi G; Rigante D; Cantarini L
    Isr Med Assoc J; 2017 Jul; 19(7):415-419. PubMed ID: 28786255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained-release dexamethasone intravitreal implant in juvenile idiopathic arthritis-related uveitis.
    Pichi F; Nucci P; Baynes K; Lowder CY; Srivastava SK
    Int Ophthalmol; 2017 Feb; 37(1):221-228. PubMed ID: 27221263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital].
    Bernard Y; Bonnin N; Farguette F; Chiambaretta F
    J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal Dexamethasone Implant for the Treatment of Macular Edema in Chronic Non-infectious Uveitis.
    Tsang AC; Virgili G; Abtahi M; Gottlieb CC
    Ocul Immunol Inflamm; 2017 Oct; 25(5):685-692. PubMed ID: 27191685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.
    Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF;
    Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema.
    Scaramuzzi M; Querques G; Spina CL; Lattanzio R; Bandello F
    Retina; 2015 Jun; 35(6):1216-22. PubMed ID: 25574787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis.
    Sella R; Oray M; Friling R; Umar L; Tugal-Tutkun I; Kramer M
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1777-82. PubMed ID: 26228441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony.
    Kong X; Psaras C; Stewart JM
    Ophthalmol Retina; 2019 Nov; 3(11):993-997. PubMed ID: 31371197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal Dexamethasone Implant for Treatment of Sarcoidosis-Related Uveitis.
    Kim M; Kim SA; Park W; Kim RY; Park YH
    Adv Ther; 2019 Aug; 36(8):2137-2146. PubMed ID: 31140122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.